ICU official logo ICU
ICU 1-star rating from Upturn Advisory
LMF Acquisition Opportunities Inc (ICU) company logo

LMF Acquisition Opportunities Inc (ICU)

LMF Acquisition Opportunities Inc (ICU) 1-star rating from Upturn Advisory
$0.51
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

11/05/2025: ICU (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $2

1 Year Target Price $2

Analysts Price Target For last 52 week
$2 Target price
52w Low $0.31
Current$0.51
52w High $3.07

Analysis of Past Performance

Type Stock
Historic Profit -47.38%
Avg. Invested days 21
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/05/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.72M USD
Price to earnings Ratio -
1Y Target Price 2
Price to earnings Ratio -
1Y Target Price 2
Volume (30-day avg) 1
Beta -1.04
52 Weeks Range 0.31 - 3.07
Updated Date 11/7/2025
52 Weeks Range 0.31 - 3.07
Updated Date 11/7/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.85

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -519.53%

Management Effectiveness

Return on Assets (TTM) -156.15%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 14188498
Price to Sales(TTM) 20.52
Enterprise Value 14188498
Price to Sales(TTM) 20.52
Enterprise Value to Revenue 18.52
Enterprise Value to EBITDA -8.13
Shares Outstanding 34096420
Shares Floating 27694350
Shares Outstanding 34096420
Shares Floating 27694350
Percent Insiders 0.82
Percent Institutions 5.84

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

LMF Acquisition Opportunities Inc

LMF Acquisition Opportunities Inc(ICU) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

LMF Acquisition Opportunities Inc. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It was founded to focus on sectors ripe for digital transformation.

Company business area logo Core Business Areas

  • Special Purpose Acquisition Company (SPAC): LMF Acquisition Opportunities Inc. operates solely as a SPAC. Its core business involves identifying and acquiring a private company, thereby taking the acquired company public. It does not have any operating business of its own. Sectors of interest are typically tech-enabled or data driven.

leadership logo Leadership and Structure

The company's leadership team typically consists of experienced dealmakers and industry veterans. The organizational structure is typical of a SPAC, with a board of directors and a management team focused on identifying and executing an acquisition.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • SPAC Acquisition: LMF Acquisition Opportunities Inc.'s primary offering is the potential for a private company to go public through a merger. There's no direct market share in the traditional sense, as each SPAC targets a specific acquisition. Competitors are other SPACs seeking deals within similar sectors.

Market Dynamics

industry overview logo Industry Overview

The SPAC market is highly dynamic and cyclical, influenced by investor sentiment, regulatory changes, and overall market conditions. It provides an alternative route for companies to go public, often faster than traditional IPOs.

Positioning

LMF Acquisition Opportunities Inc. aims to identify and acquire a company with high growth potential, operating in sectors undergoing digital transformation. Its competitive advantage lies in its management team's expertise and network.

Total Addressable Market (TAM)

The TAM depends on the target sector. It's potentially very large (billions) within tech and other areas. The positioning depends on the target company's TAM and how well the company is addressing the total addressable market

Upturn SWOT Analysis

Strengths

  • Experienced management team
  • Access to capital
  • Flexibility in deal structuring

Weaknesses

  • Reliance on finding a suitable target
  • Dilution to shareholders upon acquisition
  • Dependence on market conditions for deal success

Opportunities

  • Growing demand for alternative routes to public markets
  • Increasing number of private companies seeking to go public
  • Potential for high returns if a successful acquisition is made

Threats

  • Increased competition from other SPACs
  • Regulatory scrutiny
  • Market volatility

Competitors and Market Share

Key competitor logo Key Competitors

  • DNA
  • GGPI
  • DWAC

Competitive Landscape

The SPAC market is highly competitive, with many SPACs vying for attractive targets. Differentiation depends on the management team's experience, network, and sector focus.

Growth Trajectory and Initiatives

Historical Growth: There is no historical growth to speak of as a SPAC before acquisition.

Future Projections: Future growth is entirely dependent on the acquisition target. No specific projections can be made beforehand.

Recent Initiatives: Recent initiatives would include identifying possible acquisition targets and conducting due diligence.

Summary

LMF Acquisition Opportunities Inc. is a SPAC seeking a high-growth company to acquire. Its success depends on identifying and executing a successful merger, which is subject to market risks and competition from other SPACs. The management team's expertise is critical to navigating the complex SPAC market. Investors' returns hinge on the future performance of the acquired company.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • SEC Filings
  • Financial News Outlets
  • Company Website

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be made based on individual risk tolerance and thorough due diligence.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About LMF Acquisition Opportunities Inc

Exchange NASDAQ
Headquaters Denver, CO, United States
IPO Launch date 2022-10-28
CEO, Interim Chief Financial Officer, Principal Financial Officer, Treasurer & Executive Director Mr. Eric Schlorff
Sector Healthcare
Industry Biotechnology
Full time employees 19
Full time employees 19

SeaStar Medical Holding Corporation, a commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis. It also develops NEUTRALIZE-AKI, an SCD therapy that is in clinical trials for adult patients with AKI; and other products in various therapeutic areas, including cardiorenal syndrome, hepatorenal syndrome, and myocardial stunning in end-stage renal disease. SeaStar Medical Holding Corporation was founded in 2007 and is headquartered in Denver, Colorado.